The trial enrolled 80 women aged 45 and older diagnosed with breast cancer who were about to start neoadjuvant chemotherapy (NCT), a type of chemo given before surgery to shrink tumors. Participants were randomly assigned to receive either 2,000 IU of vitamin D daily or a placebo for six months, during their chemotherapy treatment.
Similar Posts
the benefits of de-risking cytokine release syndrome – The Health Care Blog
By SAMANTHA McCLENAHAN Every breakthrough in cancer treatment brings hope, but it also comes with a…
Taking The Wheel: A Proactive Approach to Improving Longevity
Global life expectancy has steadily grown over the last few decades and is predicted to continue…
High-Protein Freezer Meals
I cannot count the amount of times freezer meals have saved the day! There’s truly nothing…
14 Sports to Consider Trying this Summer
Sports of all kinds are a fantastic way to stay fit and get outside during the…
Natural Way of Excellent Health Care
Every year, as the rains arrive, the number of dengue cases begins to climb. A joyful…
LillyDirect Taps Walmart for First Retail Pick-Up Option for Zepbound
Eli Lilly announced a partnership with Walmart on Wednesday to expand access to its GLP-1 Zepbound…
